FDA clears IntraTherapeutics' biliary stent:
This article was originally published in Clinica
Executive Summary
St Paul, Minnesota-based IntraTherapeutics has received 510(k) clearance from the US FDA for its IntraStent DoubleStrut ParaMount biliary stent. The device consists of the company's IntraStent DoubleStrut stent and Bard's Opti-Plast XT PTA balloon catheter for delivering the stent.